Web16 Mar 2024 · Spring 2024. Recognizing the serious threat of bacterial infections, Paratek is dedicated to providing solutions that enable positive outcomes and lead to better patient … WebRT @stockresearchhq: Paratek Pharmaceuticals, Inc $PRTK quarterly revenue growth rate YoY of 242.70% ranked ⭐⭐⭐⭐⭐ in our db. Impressive! https ...
Paratek Pharmaceuticals Presenting New Data from NUZYRA® …
Web11 Apr 2024 · It’s gapping up another 23% in early morning trade from Thursday’s close. $15.64 was Thursday’s high and should be an important level of potential support today. Above it, potential targets to the upside are $18.79, $19.19, and $21, then $23.50 comes into play. Below $15.64, there is potential support at $14, $13.50 and $12.70 with $12 below … Web9 Apr 2024 · The company reported $0.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.90 by ($0.03). The company had revenue of $10.95 billion during the quarter, compared to... gummies eafit
Teri Thomas - Pharmaceutical Sales Specialist - Paratek Pharmaceuticals …
Web16 Mar 2024 · Paratek also announced its full-year 2024 revenue guidance, which is expected to be in the range of $143.0 to $158.0 million, which includes the following … Web10 Apr 2024 · Paratek retains the development and commercialization rights for sarecycline in the rest of the world. Also Read: Rubber Cement Market Size from 2024 – 2030 provides sale, revenue, trends, current development, Demand, and supply situation with a … Web20 Mar 2024 · Paratek Pharmaceuticals Announces Full-Year 2024 Revenue of $160.3 Million; Paratek Pharmaceuticals sees FY23 revenue $143M-$158M, consensus … bowling corvallis oregon